The long-term objectives are to elucidate the actions and interactions of glucocorticoids and cytokines such as gamma interferon (IFN-gamma) and interleukin 2 (IL-2) on tumor proliferation and on inactivation of the immune system. We will study these phenomena both in vitro in cell culture systems and in vivo in mice. Proposed experiments are based on numerous recent observations with these substances. They include those made on this project, which demonstrated that glucocorticoids inhibit production of lymphokines, but may inhibit or enhance their actions; and that the lymphokines, in turn, may counteract certain immunosuppressive actions of glucocorticoids, suggesting the possibility of using lymphokines to selectively counteract unwanted side effects of glucocorticoid therapy. The fact that glucocorticoids are already widely used in treatment of leukemias and lymphomas, and that lymphokines, which are now becoming generally available, are being tested experimentally in cancer therapy, emphasizes the importance of understanding interactions and mechanisms of these agents. With respect to tumoricidal activity, the specific aims are directed at two fundamental questions: (i) Do glucocorticoids in vitro or in mice alter tumoricidal activation, and in particular antibody-dependent cellular cytotoxicity (ADCC), of macrophages and other phagocytes by IFN-glamma and lymphotoxin? (ii) Do glucocorticoids alter the tumoricidal activity of interferons and lymphotoxin on glucocorticoid-sensitive and -resistant lymphoid cell lines in culture or in mice? With respect to stimulation of the immune system for bactericidal activity, the questions to be answered are: (i) Do glucocorticoids alter bactericidal activation of cultured human and mouse leukocytes by IFN-gamma plus IL-2? (ii) Can IFN-gamma and/or IL-2 reverse the increased susceptibility to infection in mice caused by glucocorticoids? Finally, using cDNA probes to measure cellular levels of mRNA for IFN-gamma and IL-2, the goals are to answer the following questions: (i) Is reduction by glucocorticoids of lymphokine mRNA levels in human T lymphocytes mediated by induced protein(s)? (ii) Are those levels under negative feedback control by the lymphokines themselves?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA017323-16
Application #
3164651
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1978-06-01
Project End
1992-05-31
Budget Start
1990-06-01
Budget End
1992-05-31
Support Year
16
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Akerley 3rd, W L; Guyre, P M; Davis, B H (1991) Neutrophil activation through high-affinity Fc gamma receptor using a monomeric antibody with unique properties. Blood 77:607-15
Guyre, P M; Campbell, A S; Kniffin, W D et al. (1990) Monocytes and polymorphonuclear neutrophils of patients with streptococcal pharyngitis express increased numbers of type I IgG Fc receptors. J Clin Invest 86:1892-6
Munck, A; Mendel, D B; Smith, L I et al. (1990) Glucocorticoid receptors and actions. Am Rev Respir Dis 141:S2-10
Pan, L Y; Mendel, D B; Zurlo, J et al. (1990) Regulation of the steady state level of Fc gamma RI mRNA by IFN-gamma and dexamethasone in human monocytes, neutrophils, and U-937 cells. J Immunol 145:267-75
Gosselin, E J; Brown, M F; Anderson, C L et al. (1990) The monoclonal antibody 41H16 detects the Leu 4 responder form of human Fc gamma RII. J Immunol 144:1817-22
Anderson, C L; Looney, R J; Culp, D J et al. (1990) Alveolar and peritoneal macrophages bear three distinct classes of Fc receptors for IgG. J Immunol 145:196-201
Guyre, P M; Graziano, R F; Vance, B A et al. (1989) Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function. J Immunol 143:1650-5
Vance, B A; Karlson, K H; Morganelli, P M et al. (1989) Single step screening of monoclonal antibodies against interferon-gamma-induced surface molecules on human monocytes. J Immunol Methods 118:287-96
Munck, A; Holbrook, N J (1988) Cyclic, nonequilibrium models of glucocorticoid antagonism: role of activation, nuclear binding and receptor recycling. J Steroid Biochem 31:599-606
Pan, L Y; Guyre, P M (1988) Individual and combined tumoricidal effects of dexamethasone and interferons on human leukocyte cell lines. Cancer Res 48:567-71

Showing the most recent 10 out of 22 publications